Cite
HARVARD Citation
Calabresi, P. et al. (2022). 018 Disease control beyond NEDA: the value of non-clinical measures to determine treatment response to natalizumab. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A19. [Online].